The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study - PubMed (original) (raw)
The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study
Carmen Stolwijk et al. Ann Rheum Dis. 2015 Jul.
Abstract
Objective: To assess the incidence and risks of common extra-articular manifestations (EAMs), that is, acute anterior uveitis (AAU), psoriasis and inflammatory bowel disease (IBD), in patients with ankylosing spondylitis (AS) compared with population-based controls.
Methods: All incident patients with AS (n=4101) from the UK Clinical Practice Research Datalink (1987-2012) were matched with up to seven control subjects without AS by year of birth, sex and practice (n=28,591). Incidence rates, cumulative incidence rates and adjusted (adj) HRs for the development of EAMs were calculated, with time-dependent adjustments for age, sex, comorbidity and medication use.
Results: At diagnosis of AS, the proportion of patients with an EAM was 11.4% for AAU, 4.4% for psoriasis and 3.7% for IBD. Incidence rates of EAMs were 8.9/1000 person-years for AAU, 3.4/1000 person-years for psoriasis and 2.4 /1000 person-years for IBD in AS. The 20-year cumulative incidence was 24.5%, 10.1% and 7.5%, respectively. Risks of EAMs were 1.5-fold to 16-fold increased versus controls, with an adj HR of 15.5 (95% CI 11.6 to 20.7) for AAU, adj HR of 1.5 (95% CI 1.1 to 1.9) for psoriasis and adj HR of 3.3 (95% CI 2.3 to 4.8) for IBD. For psoriasis and IBD, the highest risks were found in the 1st years after diagnosis, while developing AAU continued to be increased also 10 years after diagnosis of AS.
Conclusions: The risk of, in particular AAU, but also of psoriasis and IBD, is significantly increased in patients with AS compared with controls. Hazard patterns are different for each of the EAMs.
Keywords: epidemiology; inflammatory bowel disease; psoriasis; uveitis.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Similar articles
- Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS.
Essers I, Ramiro S, Stolwijk C, Blaauw M, Landewé R, van der Heijde D, Van den Bosch F, Dougados M, van Tubergen A. Essers I, et al. Rheumatology (Oxford). 2015 Apr;54(4):633-40. doi: 10.1093/rheumatology/keu388. Epub 2014 Sep 17. Rheumatology (Oxford). 2015. PMID: 25234663 - Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study.
Bengtsson K, Forsblad-d'Elia H, Deminger A, Klingberg E, Dehlin M, Exarchou S, Lindström U, Askling J, Jacobsson LTH. Bengtsson K, et al. Rheumatology (Oxford). 2021 Jun 18;60(6):2725-2734. doi: 10.1093/rheumatology/keaa692. Rheumatology (Oxford). 2021. PMID: 33216939 Free PMC article. - Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis.
Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A. Stolwijk C, et al. Ann Rheum Dis. 2015 Jan;74(1):65-73. doi: 10.1136/annrheumdis-2013-203582. Epub 2013 Sep 2. Ann Rheum Dis. 2015. PMID: 23999006 Review. - Comorbidities in patients with spondyloarthritis.
van der Horst-Bruinsma IE, Nurmohamed MT, Landewé RB. van der Horst-Bruinsma IE, et al. Rheum Dis Clin North Am. 2012 Aug;38(3):523-38. doi: 10.1016/j.rdc.2012.08.010. Epub 2012 Sep 14. Rheum Dis Clin North Am. 2012. PMID: 23083753 Review.
Cited by
- Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials.
Schreiber S, Colombel JF, Feagan BG, Reich K, Deodhar AA, McInnes IB, Porter B, Das Gupta A, Pricop L, Fox T. Schreiber S, et al. Ann Rheum Dis. 2019 Apr;78(4):473-479. doi: 10.1136/annrheumdis-2018-214273. Epub 2019 Jan 23. Ann Rheum Dis. 2019. PMID: 30674475 Free PMC article. - Managing Psoriatic Arthritis With Inflammatory Bowel Disease and/or Uveitis.
Chia AYT, Ang GWX, Chan ASY, Chan W, Chong TKY, Leung YY. Chia AYT, et al. Front Med (Lausanne). 2021 Sep 16;8:737256. doi: 10.3389/fmed.2021.737256. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34604268 Free PMC article. Review. - Neurologically Asymptomatic Lumbar Traumatic Dislocation With Vascular Compression in a Patient With Ankylosing Spondylitis: Case Report.
Mata-Gómez J, Gilete-Tejero IJ, Rico-Cotelo M, Royano-Sánchez M, Moreno-Flores A, Ortega-Martínez M. Mata-Gómez J, et al. Int J Spine Surg. 2021 Feb;14(s4):S16-S20. doi: 10.14444/7159. Epub 2020 Dec 29. Int J Spine Surg. 2021. PMID: 33900939 Free PMC article. - Effects of etanercept and infliximab on bone metabolism indexes in patients with ankylosing spondylitis.
Wang C, Li W. Wang C, et al. Exp Ther Med. 2020 Jan;19(1):585-590. doi: 10.3892/etm.2019.8266. Epub 2019 Dec 2. Exp Ther Med. 2020. PMID: 31885700 Free PMC article. - Healthcare Utilization and Direct Costs in Patients with Ankylosing Spondylitis Using a Large US Administrative Claims Database.
Walsh JA, Song X, Kim G, Park Y. Walsh JA, et al. Rheumatol Ther. 2018 Dec;5(2):463-474. doi: 10.1007/s40744-018-0124-4. Epub 2018 Aug 18. Rheumatol Ther. 2018. PMID: 30121826 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials